Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Synergistic effect of ponatinib and epigallocatechin-3-gallate induces apoptosis in chronic myeloid leukemia cells through altering expressions of cell cycle regulatory genesBakiye Goker, Cansu Caliskan, Hasan Onur Caglar, et al.
International Journal of Hematologic Oncology|June 6, 2022
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemiaGuray Saydam, Ridvan Ali, Ahmet Muzaffer Demir, et al.
Expert Opinion on Pharmacotherapy|August 9, 2016
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phaseGuray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
Hematology (Amsterdam, Netherlands)|July 13, 2018
Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-upGuray Saydam, Ibrahim Celalettin Haznedaroglu, Leylagul Kaynar, et al.
Hematology (Amsterdam, Netherlands)|March 1, 2018
Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phaseGuray Saydam, Ibrahim C Haznedaroglu, Leylagul Kaynar, et al.
American Journal of Blood Research|August 30, 2016
Pesg PNH diagnosis, follow-up and treatment guidelinesFahri Sahin, Olga Meltem Akay, Mesut Ayer, et al.
Clinical Laboratory|September 9, 2020
Study for the Diagnostic Screening of Paroxysmal Nocturnal Hemoglobinuria in Older Patients with Unexplained Anemia and/or CytopeniaZehra N Ozdemir, Osman Ilhan, Gulsum Ozet, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|September 23, 2019
Study for the diagnostic screening of paroxsymal nocturnal hemoglobinuria in Turkey: Prospective multicentric evaluation of suspected patientsOsman Ilhan, Zehra Narli Ozdemir, Gulsum Ozet, et al.
International Journal of Hematologic Oncology|September 14, 2022
Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemiaGuray Saydam, Ali Unal, Ibrahim Celalettin Haznedaroglu, et al.
The Lancet. Oncology|April 13, 2021
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trialMatthew J Matasar, Marcelo Capra, Muhit Özcan, et al.
Pageof 8